UK markets closed

OrthoPediatrics Corp. (KIDS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
28.76-0.03 (-0.10%)
At close: 04:00PM EDT
28.76 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 685.32M
Enterprise value 647.88M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.04
Price/book (mrq)1.85
Enterprise value/revenue 4.00
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3-32.98%
S&P500 52-week change 322.55%
52-week high 345.96
52-week low 323.10
50-day moving average 331.03
200-day moving average 329.47

Share statistics

Avg vol (3-month) 3150.39k
Avg vol (10-day) 3177.55k
Shares outstanding 523.83M
Implied shares outstanding 623.83M
Float 815.95M
% held by insiders 133.09%
% held by institutions 169.81%
Shares short (14 Jun 2024) 41.04M
Short ratio (14 Jun 2024) 411.06
Short % of float (14 Jun 2024) 416.70%
Short % of shares outstanding (14 Jun 2024) 44.38%
Shares short (prior month 15 May 2024) 41.16M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -13.58%
Operating margin (ttm)-21.76%

Management effectiveness

Return on assets (ttm)-3.89%
Return on equity (ttm)-5.91%

Income statement

Revenue (ttm)161.83M
Revenue per share (ttm)7.11
Quarterly revenue growth (yoy)41.50%
Gross profit (ttm)N/A
EBITDA -8.33M
Net income avi to common (ttm)-21.97M
Diluted EPS (ttm)-0.96
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)47.74M
Total cash per share (mrq)2
Total debt (mrq)12.54M
Total debt/equity (mrq)3.38%
Current ratio (mrq)4.45
Book value per share (mrq)15.74

Cash flow statement

Operating cash flow (ttm)-27.27M
Levered free cash flow (ttm)-36.51M